Viewing Study NCT03936894


Ignite Creation Date: 2025-12-25 @ 1:31 AM
Ignite Modification Date: 2026-01-04 @ 11:12 PM
Study NCT ID: NCT03936894
Status: UNKNOWN
Last Update Posted: 2023-09-21
First Post: 2019-04-29
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Single Escalating Dose Pilot Trial of Canakinumab (ILARISĀ®) in Duchenne Muscular Dystrophy
Sponsor: Children's National Research Institute
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Duchenne Muscular Dystrophy View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Canakinumab View
None Biomarker View